Protect your investment by auditing the five critical risk areas in every specialty vet practice acquisition — from specialist contracts to referral concentration and DEA compliance.
Acquiring a veterinary specialty practice offers access to a high-barrier, recession-resistant healthcare services business with strong EBITDA margins and growing demand. But the sector carries unique risks that general business due diligence frameworks miss entirely. Specialist retention, referral network dependency, controlled substance compliance, and the condition of six-figure diagnostic equipment can each make or break a deal. This checklist walks buyers — whether PE-backed consolidators, individual veterinarians, or SBA borrowers — through the five essential due diligence categories specific to veterinary specialty acquisitions in the $1.5M–$5M revenue range.
Board-certified specialists are the revenue engine of any specialty practice. Losing one post-close can trigger immediate referral and revenue collapse.
Review all specialist employment contracts for assignability, non-compete terms, and expiration dates.
An unassignable or expiring contract means your highest-value clinician has no legal obligation to stay post-close.
Red flag: Any specialist is on a month-to-month arrangement or has no written employment agreement in place.
Assess each specialist's tenure, compensation structure, and known departure intentions.
Specialists with competing offers or retirement plans represent immediate revenue-at-risk that may not show in trailing financials.
Red flag: The practice's top revenue-generating specialist is within 24 months of a stated or implied retirement.
Identify what percentage of total revenue is attributable to each individual specialist.
Revenue concentration in one clinician creates catastrophic downside if that person exits post-acquisition.
Red flag: A single specialist accounts for more than 50% of total practice revenue.
Evaluate non-compete geographic scope and enforceability under applicable state law.
Non-competes that are unenforceable leave you with no legal protection if a specialist leaves and opens a competing clinic nearby.
Red flag: Non-compete clauses are vague, unreviewed by counsel, or located in a state with near-total non-compete bans.
Specialty practices live and die by general practitioner referrals. Understanding who sends cases — and whether those relationships survive ownership change — is non-negotiable.
Obtain a full 24-month referral source report showing case volume and revenue by referring practice.
Referral concentration risk is invisible without data — top sources may account for the majority of all revenue.
Red flag: The top three referring practices represent more than 40% of total annual revenue.
Assess whether referral relationships are personal to the selling specialist or transferable to the practice brand.
If referring GPs are loyal to the seller personally, those relationships may dissolve the moment ownership changes.
Red flag: Referral volumes correlate tightly with one departing specialist's personal relationships with no documented practice-level outreach program.
Request any written referral agreements, service level commitments, or loyalty program documentation.
Formalized relationships are more durable post-close than informal ones built entirely on personal goodwill.
Red flag: Zero written referral agreements exist and no structured communication program with referring GPs is in place.
Interview two to three key referring practice managers or DVMs as part of confirmatory diligence.
Direct conversations reveal loyalty levels, complaints, and any awareness of ownership transition that could accelerate defection.
Red flag: Referring DVMs express discomfort with ownership change or mention they are already trialing a competing specialty group.
Specialty practices handle Schedule II–IV controlled substances daily. A single compliance failure can void DEA registration, triggering immediate operational shutdown.
Obtain and review the DEA registration certificate, renewal status, and full inspection history.
DEA registration is non-transferable — the buyer must apply for a new registration, and a revoked or suspended history creates approval risk.
Red flag: Any prior DEA warning letter, inspection citation, or unresolved controlled substance discrepancy in the past five years.
Review state veterinary board licensing for all specialists and the practice entity itself.
State board complaints or license conditions can restrict the practice's legal ability to offer certain specialty services post-close.
Red flag: Any open state board investigation, probationary license condition, or unresolved malpractice complaint against a key specialist.
Audit controlled substance logs, disposal records, and inventory reconciliation for the past 24 months.
Sloppy CS recordkeeping signals systemic compliance weakness and DEA audit exposure that transfers to the buyer.
Red flag: Missing disposal records, unexplained inventory discrepancies, or informal paper logs not reconciled to dispensing software.
Review OSHA compliance records, radiation safety logs, and hazardous waste disposal documentation.
Specialty practices using MRI, CT, and radiography carry regulatory obligations that, if violated, create fines and operational interruption risk.
Red flag: No radiation safety officer designated, missing OSHA 300 logs, or improper disposal of pharmaceutical or radiological waste.
High-value imaging and surgical equipment defines specialty capability. Deferred maintenance or aging assets can mean $500K–$2M+ in capex within 18 months of close.
Commission an independent appraisal of all major diagnostic assets including MRI, CT, ultrasound, and endoscopy systems.
Seller-reported book value rarely reflects actual fair market or replacement value — third-party appraisal protects your SBA collateral analysis.
Red flag: No formal appraisal exists and equipment ages are unknown or understated by the seller.
Request full maintenance logs, service contracts, and manufacturer support status for each major unit.
Equipment without active service contracts or running on discontinued manufacturer support is a hidden capex time bomb.
Red flag: MRI or CT unit is beyond manufacturer support window with no active service contract and deferred maintenance backlog.
Assess remaining useful life and replacement cost for each piece of imaging and surgical equipment.
Modeling true buyer-side capex requirements over a five-year horizon is essential to validating EBITDA and deal pricing.
Red flag: More than one major diagnostic system will require replacement within 24 months, creating unmodeled capex exceeding $300K.
Verify ownership versus lease status and review all equipment financing agreements for change-of-control provisions.
Equipment leases with change-of-control termination clauses can strip key assets from the deal at closing without warning.
Red flag: Key imaging equipment is leased under an agreement with a change-of-control default clause the seller has not disclosed.
Specialty veterinary revenue is driven by high-value procedures but increasingly influenced by pet insurance reimbursements and client ability to pay for premium care.
Obtain three years of tax returns, P&Ls, and balance sheets with all owner add-backs fully documented.
Undocumented or inflated add-backs distort true EBITDA and can lead to significant overpayment on a multiple-based deal.
Red flag: Seller cannot provide tax returns consistent with stated revenue or add-backs lack supporting documentation.
Analyze accounts receivable aging report with breakout by payor type including pet insurance, direct pay, and CareCredit.
A high percentage of aged receivables or denied insurance claims signals billing dysfunction and overstated revenue quality.
Red flag: More than 20% of AR is over 90 days or pet insurance denial rates are significantly above industry norms.
Review pet insurance reimbursement rates, claim turnaround times, and denial history by insurer.
As pet insurance penetration grows, payor mix complexity increasingly affects specialty practice cash flow predictability.
Red flag: A major insurer has recently reduced reimbursement rates for key procedures performed by this practice.
Evaluate revenue trends by service line and case type over the prior 36 months.
Declining case volume in a core specialty — even with flat total revenue — may indicate early referral erosion not yet visible in aggregate numbers.
Red flag: Oncology, surgery, or internal medicine case counts are declining YoY even as average case revenue rises, masking volume loss.
Find Veterinary Specialty Practice Businesses For Sale
Vetted targets with diligence packages — skip the cold search.
Veterinary specialty practices in the $1.5M–$5M revenue range typically sell at 4.5x–7.5x EBITDA. The high end of that range is reserved for practices with multiple board-certified specialists across disciplines, diversified referral networks spanning 20 or more general practices, EBITDA margins of 20%+, and modern owned diagnostic equipment. Single-specialist practices or those with heavy referral concentration trade at the lower end of the range. PE-backed consolidators often pay strategic premiums above 7x when acquiring a practice that fills a geographic or specialty gap in their existing network.
Yes. Veterinary specialty practices are SBA-eligible businesses and the SBA 7(a) program is commonly used to finance 80–90% of the purchase price with a buyer equity injection of 10–15%. Lenders familiar with veterinary transactions will want to see at least two years of stable financials, a clear specialist retention plan, and an equipment appraisal to establish collateral value. DEA registration history and any open state board matters will also be scrutinized. Working with an SBA lender that has prior veterinary healthcare deal experience significantly improves approval speed and structure quality.
Specialist departure is the single highest-impact post-acquisition risk. Unlike general practice veterinarians, board-certified specialists are nationally scarce — fewer than 10,000 exist across all disciplines in the U.S. — and they carry significant negotiating leverage. If the practice's primary revenue-generating specialist leaves within 12 months of close, referral volumes can collapse within 60 to 90 days as referring GPs redirect cases to competing practices. Buyers should structure earnouts tied to specialist retention, negotiate robust employment agreements prior to close, and consider offering equity participation to key clinicians as a long-term retention mechanism.
Start with 24 months of referral source data broken down by case volume and revenue per referring practice. Then assess whether those relationships are tied to the selling specialist personally or to the practice brand more broadly. The most durable referral networks have a history of multiple touchpoints — case communications, continuing education events, and practice liaison visits — that are not dependent on one individual. As part of confirmatory diligence, request permission to speak directly with two or three key referring DVMs. Their candor about the ownership change will tell you more about referral continuity risk than any spreadsheet.
More Veterinary Specialty Practice Guides
More Due Diligence Checklists
Stop cold-searching. Find signal-scored Veterinary Specialty Practice targets with seller motivation already identified.
Create your free accountNo credit card required
For Buyers
For Sellers